SEC Form 4 · accession 0001437749-16-043884
VIVEVE MEDICAL, INC. · VIVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James G. Atkinson
Director
Period of report
Dec 23, 2016
Accepted (ET)
Dec 28, 2016 · 9:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879682
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (Right to Purchase)F1 | $5.22 | Dec 23, 2016 | A | 75,000 | A | — | Dec 22, 2026 | Common Stock | 75,000 | 75,000 | D |
| Incentive Stock Option (Right to Purchase)F2 | $5.22 | Dec 23, 2016 | A | 2,250 | A | Dec 23, 2016 | Dec 22, 2026 | Common Stock | 2,250 | 2,250 | D |
Explanation of responses
- F1The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan (the "Plan") and received 75,000 incentive stock options on December 23, 2016 (the "Grant Date"). The incentive stock options will vest in equal monthly increments over 48 months following the Grant Date.
- F2The reporting person is a participant in the Plan and received 2,250 incentive stock options on December 23, 2016 (the "Grant Date"). The incentive stock options vested in full on the Grant Date.